These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10951150

  • 41. Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan.
    Yasuda S, Atsumi T, Shimamura S, Ono K, Hiromura K, Sada K, Mori M, Takei S, Kawaguchi Y, Tamura N, Takasaki Y.
    Mod Rheumatol; 2015; 25(6):854-7. PubMed ID: 25800636
    [Abstract] [Full Text] [Related]

  • 42. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
    Budde K, Glander P, Diekmann F, Dragun D, Waiser J, Fritsche L, Neumayer HH.
    Transplant Proc; 2004 Mar; 36(2 Suppl):524S-527S. PubMed ID: 15041401
    [Abstract] [Full Text] [Related]

  • 43. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
    Sanders DB, Hart IK, Mantegazza R, Shukla SS, Siddiqi ZA, De Baets MH, Melms A, Nicolle MW, Solomons N, Richman DP.
    Neurology; 2008 Aug 05; 71(6):400-6. PubMed ID: 18434638
    [Abstract] [Full Text] [Related]

  • 44. Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy.
    Lv J, Zhang H, Cui Z, Su T, Zhang Y, Wang H.
    Nephrol Dial Transplant; 2008 Sep 05; 23(9):2868-72. PubMed ID: 18463325
    [Abstract] [Full Text] [Related]

  • 45. Limits to intensified mycophenolate mofetil dosing in kidney transplantation.
    Kiberd BA, Lawen J, Daley C.
    Ther Drug Monit; 2012 Dec 05; 34(6):736-8. PubMed ID: 23007746
    [Abstract] [Full Text] [Related]

  • 46. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
    Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A.
    Br J Dermatol; 2004 Jan 05; 150(1):132-5. PubMed ID: 14746627
    [Abstract] [Full Text] [Related]

  • 47. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy.
    Majithia V, Harisdangkul V.
    Rheumatology (Oxford); 2005 Mar 05; 44(3):386-9. PubMed ID: 15572389
    [Abstract] [Full Text] [Related]

  • 48. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
    Zhou Y, Rosenthal D, Dutz J, Ho V.
    J Cutan Med Surg; 2003 Mar 05; 7(3):193-7. PubMed ID: 12704533
    [Abstract] [Full Text] [Related]

  • 49. Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.
    Tse KC, Tang CS, Lio WI, Lam MF, Chan TM.
    Lupus; 2006 Mar 05; 15(6):371-9. PubMed ID: 16830884
    [Abstract] [Full Text] [Related]

  • 50. Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease.
    Adler YD, Mansmann U, Zouboulis CC.
    Dermatology; 2001 Mar 05; 203(4):322-4. PubMed ID: 11752821
    [Abstract] [Full Text] [Related]

  • 51. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan 05; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

  • 52. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M.
    Clin Nephrol; 1996 May 05; 45(5):336-41. PubMed ID: 8738667
    [Abstract] [Full Text] [Related]

  • 53. Mycophenolate mofetil as a treatment for urticarial dermatitis.
    Chaptini C, Sidhu S.
    Australas J Dermatol; 2014 Nov 05; 55(4):275-8. PubMed ID: 25178716
    [Abstract] [Full Text] [Related]

  • 54. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
    Haufs MG, Beissert S, Grabbe S, Schütte B, Luger TA.
    Br J Dermatol; 1998 Jan 05; 138(1):179-81. PubMed ID: 9536244
    [Abstract] [Full Text] [Related]

  • 55. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

  • 56. The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.
    Chen H, Zhang Y, Shi Z, Feng H, Yao S, Xie J, Zhou H.
    Clin Neuropharmacol; 2016 Jan 27; 39(2):81-7. PubMed ID: 26818042
    [Abstract] [Full Text] [Related]

  • 57. Mycophenolate mofetil-induced colitis in children.
    Phatak UP, Seo-Mayer P, Jain D, Selbst M, Husain S, Pashankar DS.
    J Clin Gastroenterol; 2009 Jan 27; 43(10):967-9. PubMed ID: 19609219
    [Abstract] [Full Text] [Related]

  • 58. Uncommon side effect of MMF in renal transplant recipients.
    Balal M, Demir E, Paydas S, Sertdemir Y, Erken U.
    Ren Fail; 2005 Jan 27; 27(5):591-4. PubMed ID: 16152998
    [Abstract] [Full Text] [Related]

  • 59. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma.
    Stratton RJ, Wilson H, Black CM.
    Rheumatology (Oxford); 2001 Jan 27; 40(1):84-8. PubMed ID: 11157146
    [Abstract] [Full Text] [Related]

  • 60. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial.
    Reis A, Reinhard T, Voiculescu A, Kutkuhn B, Godehardt E, Spelsberg H, Althaus C, Sundmacher R.
    Br J Ophthalmol; 1999 Nov 27; 83(11):1268-71. PubMed ID: 10535855
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.